WO2020176052A1 - A respiratory support device with artificial intelligence - Google Patents
A respiratory support device with artificial intelligence Download PDFInfo
- Publication number
- WO2020176052A1 WO2020176052A1 PCT/TR2019/051264 TR2019051264W WO2020176052A1 WO 2020176052 A1 WO2020176052 A1 WO 2020176052A1 TR 2019051264 W TR2019051264 W TR 2019051264W WO 2020176052 A1 WO2020176052 A1 WO 2020176052A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- oxygen
- artificial intelligence
- airway
- apnea
- Prior art date
Links
- 238000013473 artificial intelligence Methods 0.000 title claims abstract description 18
- 230000000241 respiratory effect Effects 0.000 title claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 33
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 33
- 239000001301 oxygen Substances 0.000 claims abstract description 33
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 206010041235 Snoring Diseases 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 230000033001 locomotion Effects 0.000 claims description 3
- 230000003187 abdominal effect Effects 0.000 claims description 2
- 239000001569 carbon dioxide Substances 0.000 claims description 2
- 210000000038 chest Anatomy 0.000 claims description 2
- 201000002859 sleep apnea Diseases 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 208000008784 apnea Diseases 0.000 description 11
- 239000003570 air Substances 0.000 description 10
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 6
- 208000029618 autoimmune pulmonary alveolar proteinosis Diseases 0.000 description 6
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 208000001797 obstructive sleep apnea Diseases 0.000 description 5
- 241001552669 Adonis annua Species 0.000 description 4
- 208000019693 Lung disease Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010021079 Hypopnoea Diseases 0.000 description 3
- 239000012080 ambient air Substances 0.000 description 3
- 238000010801 machine learning Methods 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229910001882 dioxygen Inorganic materials 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 238000002640 oxygen therapy Methods 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940127554 medical product Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
- A61M16/026—Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0057—Pumps therefor
- A61M16/0066—Blowers or centrifugal pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/06—Respiratory or anaesthetic masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
- A61M16/122—Preparation of respiratory gases or vapours by mixing different gases with dilution
- A61M16/125—Diluting primary gas with ambient air
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0027—Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
- A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/205—Blood composition characteristics partial oxygen pressure (P-O2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/40—Respiratory characteristics
- A61M2230/43—Composition of exhalation
- A61M2230/432—Composition of exhalation partial CO2 pressure (P-CO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/62—Posture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/63—Motion, e.g. physical activity
Definitions
- the present invention relates to a next-generation artificial intelligence-based PAP (Positive Airway Pressure) device that collects physiological data from the patient for use by patients with occlusive sleep apnea and transmits oxygen-enriched air to the airway of the patient by synchronizing with the oxygen source if necessary, and can perform a personal therapy specific to the patient.
- PAP Personal Airway Pressure
- the obstructive sleep apnea is when the breath path closes completely or partially during sleep and the amount of oxygen in the blood drops rapidly.
- PAP devices CPAP, APAP, BiPAP, etc.
- APAP Automatic PAP
- the number of parameters of the algorithms already produced and used by the APAP devices used by the patients is limited. These devices usually adjust the air pressure with airflow and pressure sensors.
- the pressure of the air required to be given to the patient is calculated according to the data obtained from the pressure and airflow sensors and the appropriate air value is transmitted to the airway of the patient.
- the patient is able to breathe comfortably again by eliminating the obstruction or narrowing of the airway.
- old-fashioned APAP devices work to eliminate the problem after the airway narrowing or obstruction of the patient occurs. None of the currently manufactured APAP devices operates according to the principle of preventing obstructive apnea problem before it occurs. This is a technical problem that needs to be addressed for the treatment of obstructive sleep apnea.
- the invention is a computer system embedded to process the data read from these sensors and calculate the appropriate outputs to instantly monitor the condition of the patient, a blower motor used to generate positive air pressure wherein it consists of an algorithm encoded according to an algorithm prepared by artificial intelligence, machine learning, and automated control techniques to ensure adequate oxygenation, and to ensure that all of these units operate in a harmonious and purposeful manner.
- the present invention comprises a software (6) containing an embedded computer system (1 ) a sensor (2) a blower motor (3), an oxygen supply (4), a mask and a hose (5) and an artificial intelligence module (6.1 ), an automatic control module (6.2) and an interface module (6.3) sections.
- the obstructive apnea disease occurs as a narrowing (hypopnea) or obstruction (apnea) in the breathing path of the patient during sleep.
- This obstruction which occurs beyond the will of the individual, results in the person not being able to adequately breathe and not receive sufficient oxygen. This causes the blood to drop in oxygen.
- apnea or hypopnea the patient usually wakes up and the re-opening of the airway occurs as a result of the patient waking up. This causes frequent interruptions of the sleep of the patient and patient insomnia. This discomfort can trigger many diseases, especially heart diseases, as well as the patient's inability to remain awake.
- the frequency of the obstructive sleep apnea in adult men is up to 17%, and for women, it is up to 9% (Mendonga et al. , 2018). As these rates can be seen, the obstructive sleep apnea is a very important public health problem.
- the invention allows the physiological values (O2 density in the blood, CO2 density in the breathing, abdominal muscle movements, snoring status, body position, airway pressure, airflow, etc.) that are generated in the patient's body during sleep to be transferred to the embedded computer system by means of various sensors (2).
- the embedded computer system (1 ) recognizes the patient's body and learns the values that will be generated through software (6), which is built with artificial intelligence and machine learning algorithms (6.1 ). This allows the system to cut apnea that may occur later based on the physiological values that occurred during the previous time period.
- the present invention works differently from older type PAP devices, as this intervention is not to solve a resulting apnea problem but to prevent apnea from occurring. Therefore, the present invention can be called the next generation PAP device based on artificial intelligence (6.1 ).
- Legacy PAP devices CPAP, APAP, BIPAP, ETC.
- CPAP, APAP, BIPAP, ETC. only receive data from the patient with pressure and fluidity sensors.
- the next generation PAP device based on artificial intelligence (6.1 ) is available with these sensors, as well as the carbon dioxide sensor, oxygen sensor, snoring sensor, abdominal and thorax motion sensor, body position sensor, jaw-neck electrode and pulse oximeter, etc., it collects data via various sensors (2). These features provide immediate physiological data collection from the patient, which is the unique aspect of the invention. Older types of devices do not have a system that learns the patient's sleep state.
- the next-generation PAP device is a device that learns and responds to a patient's sleep state overnight through artificial intelligence (6.1 ) and machine learning techniques to develop.
- the new generation of PAP equipment based on artificial intelligence (6.1 )
- the invention will work in synchronization with the pulse oximeter device to determine the oxygen ratio in the blood of the patient.
- the oxygen content of the patient in the blood drops.
- additional oxygen therapy may be required for the patient if the amount of oxygen in the ambient air is not sufficient or if the patient does not have sufficient lung disease to use oxygen in the environment.
- Another unique aspect of the present invention is the synchronization of the oxygen supply (4) with the next generation PAP device based on artificial intelligence (6.1 ).
- PAP devices on the market do not have the ability to synchronize with the oxygen source (4).
- the oxygen source (4) can be synchronized, allowing the patient to receive oxygen-enriched air that is needed.
- the invention can solve the apnea problem, which can pose dangerous consequences for patients with lung disease, especially for asthma and COPD (Chronic Obstructive Lung Disease), while at the same time enriching the air to be delivered to the airway of the patients with oxygen when needed, thus transmitting it to the patient.
- the present invention synchronizes with the next generation PAP device based on artificial intelligence and an oxygen source (4).
- the system also allows ambient air to be delivered to the patient along with oxygen gas from the oxygen source (4) to achieve the desired level of oxygen density in the blood of the patient. This process is instantaneously evaluated based on the physiological data received from the patient and is provided by software (6), which is encoded with artificial intelligence algorithms (6.1 ), to enable the supply of oxygen when needed.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Artificial Intelligence (AREA)
- Mathematical Physics (AREA)
- Optics & Photonics (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The present invention relates to a next-generation artificial intelligence-based PAP (Positive Airway Pressure) device that collects physiological data from the patient for use by patients with occlusive sleep apnea and transmits oxygen-enriched air to the airway of the patient by synchronizing with the oxygen source if necessary, and can perform a personal therapy specific to the patient.
Description
A RESPIRATORY SUPPORT DEVICE WITH ARTIFICIAL INTELLIGENCE
TECHNICAL FIELD
The present invention relates to a next-generation artificial intelligence-based PAP (Positive Airway Pressure) device that collects physiological data from the patient for use by patients with occlusive sleep apnea and transmits oxygen-enriched air to the airway of the patient by synchronizing with the oxygen source if necessary, and can perform a personal therapy specific to the patient.
PRIOR ART
The obstructive sleep apnea is when the breath path closes completely or partially during sleep and the amount of oxygen in the blood drops rapidly. To prevent this, the patients use PAP devices (CPAP, APAP, BiPAP, etc.) while sleeping at their homes at night. These devices send compressed air to the patient's airway to prevent narrowing or obstruction of the airway of the patient. There are different types of PAP devices in the medical products market. These devices are called APAP (Automatic PAP), which adjust the pressure value of the air it sends according to the obstruction in the airway. The number of parameters of the algorithms already produced and used by the APAP devices used by the patients is limited. These devices usually adjust the air pressure with airflow and pressure sensors. Thus, when a narrowing or obstruction occurs in the airway of the patient during sleep, the pressure of the air required to be given to the patient is calculated according to the data obtained from the pressure and airflow sensors and the appropriate air value is transmitted to the airway of the patient. In this way, the patient is able to breathe comfortably again by eliminating the obstruction or narrowing of the airway. As mentioned above, old-fashioned APAP devices work to eliminate the problem after the airway narrowing or obstruction of the patient occurs. None of the currently manufactured APAP devices operates according to the principle of preventing obstructive apnea problem before it occurs. This is a technical problem that needs to be addressed for the treatment of obstructive sleep apnea. In patients with obstructive sleep apnea, obstruction of the airway causes the problem of inability to reach enough oxygen to the lungs and as a result of this, the oxygen ratio in the blood drops rapidly. This is the most basic problem for all sleep apnea
patients. This problem is particularly at risk of having more hazardous consequences for sleep apnea patients with pulmonary disease, such as asthma and COPD (Chronic Obstructive Lung disease). Because of this type of patient, the oxygen content in the blood drops faster due to insufficient utilization of oxygen and insufficient oxygenation in the ambient air due to lung disease (especially COPD), and patients need additional oxygen therapy. Because old type PAP devices do not have this feature, patients are supplied with additional oxygen from the oxygen tube. Patients are also at risk of oxygen poisoning due to excessive oxygen during therapy, as there are no control mechanisms that adjust this delivered oxygen gas to the immediate need of the patient. This issue is also a problem that needs to be addressed in light of new technological developments.
BRIEF DESCRIPTION OF THE INVENTION
The invention is a computer system embedded to process the data read from these sensors and calculate the appropriate outputs to instantly monitor the condition of the patient, a blower motor used to generate positive air pressure wherein it consists of an algorithm encoded according to an algorithm prepared by artificial intelligence, machine learning, and automated control techniques to ensure adequate oxygenation, and to ensure that all of these units operate in a harmonious and purposeful manner.
LIST OF THE FIGURES
Figure 1. General View of the Device
Figure 2. Algorithm Flow Chart
Naming the part numbers indicated in the figures with the part number
1. Embedded Computer System
2. Sensors
3. Blower Engine
4. Oxygen Source
5. Mask and Hose
6. Software
6.1. Artificial Intelligence Module
6.2. Automatic Control Module
6.3. Interface Module
DETAILED DESCRIPTION OF THE INVENTION
The present invention comprises a software (6) containing an embedded computer system (1 ) a sensor (2) a blower motor (3), an oxygen supply (4), a mask and a hose (5) and an artificial intelligence module (6.1 ), an automatic control module (6.2) and an interface module (6.3) sections.
The obstructive apnea disease occurs as a narrowing (hypopnea) or obstruction (apnea) in the breathing path of the patient during sleep. This obstruction, which occurs beyond the will of the individual, results in the person not being able to adequately breathe and not receive sufficient oxygen. This causes the blood to drop in oxygen. As a result of apnea or hypopnea, the patient usually wakes up and the re-opening of the airway occurs as a result of the patient waking up. This causes frequent interruptions of the sleep of the patient and patient insomnia. This discomfort can trigger many diseases, especially heart diseases, as well as the patient's inability to remain awake. According to recent research, the frequency of the obstructive sleep apnea in adult men is up to 17%, and for women, it is up to 9% (Mendonga et al. , 2018). As these rates can be seen, the obstructive sleep apnea is a very important public health problem.
The invention allows the physiological values (O2 density in the blood, CO2 density in the breathing, abdominal muscle movements, snoring status, body position, airway pressure, airflow, etc.) that are generated in the patient's body during sleep to be transferred to the embedded computer system by means of various sensors (2). The embedded computer system (1 ) recognizes the patient's body and learns the values that will be generated through software (6), which is built with artificial intelligence and machine learning algorithms (6.1 ). This allows the system to cut apnea that may occur later based on the physiological values that occurred during the previous time period. This allows the system to pre-intervene before the patient enters the apnea, delivering the required positive air to the patient's airway to prevent the patient from entering the apnea. The present invention works differently from older type PAP devices, as this intervention is not to solve a resulting apnea problem but to prevent apnea from occurring. Therefore, the present invention can be called the next generation PAP device based on artificial intelligence (6.1 ).
Legacy PAP devices (CPAP, APAP, BIPAP, ETC.) only receive data from the patient with pressure and fluidity sensors. With this invention, the next generation PAP device based on artificial intelligence (6.1 ) is available with these sensors, as well as the carbon dioxide sensor, oxygen sensor, snoring sensor, abdominal and thorax motion sensor, body position sensor, jaw-neck electrode and pulse oximeter, etc., it collects data via various sensors (2). These features provide immediate physiological data collection from the patient, which is the unique aspect of the invention. Older types of devices do not have a system that learns the patient's sleep state. The next-generation PAP device is a device that learns and responds to a patient's sleep state overnight through artificial intelligence (6.1 ) and machine learning techniques to develop. The new generation of PAP equipment based on artificial intelligence (6.1 ), the invention will work in synchronization with the pulse oximeter device to determine the oxygen ratio in the blood of the patient. In the case of apnea and hypopnea, the oxygen content of the patient in the blood drops. In order to maintain the blood oxygen level of the patient at the normal level, additional oxygen therapy may be required for the patient if the amount of oxygen in the ambient air is not sufficient or if the patient does not have sufficient lung disease to use oxygen in the environment. Another unique aspect of the present invention is the synchronization of the oxygen supply (4) with the next generation PAP device based on artificial intelligence (6.1 ). PAP devices on the market do not have the ability to synchronize with the oxygen source (4). With the next-generation PAP device based on artificial intelligence (6.1 ), the oxygen source (4) can be synchronized, allowing the patient to receive oxygen-enriched air that is needed.
The invention can solve the apnea problem, which can pose dangerous consequences for patients with lung disease, especially for asthma and COPD (Chronic Obstructive Lung Disease), while at the same time enriching the air to be delivered to the airway of the patients with oxygen when needed, thus transmitting it to the patient. To do this, the present invention synchronizes with the next generation PAP device based on artificial intelligence and an oxygen source (4). The system also allows ambient air to be delivered to the patient along with oxygen gas from the oxygen source (4) to achieve the desired level of oxygen density in the blood of the patient. This process is instantaneously evaluated based on the physiological data received from the patient and is provided by software (6), which is encoded with artificial intelligence algorithms (6.1 ), to enable the supply of oxygen when needed.
Claims
1. A respiratory support device with artificial intelligence characterized by comprising an embedded computer system (1 ) which further comprises a software (6) and the software (6) comprising an artificial intelligence module (6.1 ), an automatic control module (6.2), an interface module (6.3) sections processing the data received from a sensor (2) and the carbon dioxide, oxygen, snoring, abdominal/thorax motion, body position, jaw-neck electrode, pulse oximeter sensors (2) instantaneously receiving physiological values from the patient during sleep.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2019/02913A TR201902913A2 (en) | 2019-02-27 | 2019-02-27 | ARTIFICIAL INTELLIGENCE BASED RESPIRATORY SUPPORT DEVICE |
TR2019/02913 | 2019-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020176052A1 true WO2020176052A1 (en) | 2020-09-03 |
Family
ID=67981026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2019/051264 WO2020176052A1 (en) | 2019-02-27 | 2019-12-31 | A respiratory support device with artificial intelligence |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201902913A2 (en) |
WO (1) | WO2020176052A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050188991A1 (en) * | 2003-06-04 | 2005-09-01 | Jianuo Sun | Positive airway pressure therapy management module |
US20130046151A1 (en) * | 2011-02-14 | 2013-02-21 | The Board Of Regents Of The University Of Texas System | System and method for real-time measurement of sleep quality |
CN103690168A (en) * | 2013-12-31 | 2014-04-02 | 中国科学院深圳先进技术研究院 | Method and system for detecting obstructive sleep apnea syndrome |
US9730632B1 (en) * | 2005-11-04 | 2017-08-15 | Cleveland Medical Devices Inc | Integrated sleep diagnostic and therapeutic system and method |
-
2019
- 2019-02-27 TR TR2019/02913A patent/TR201902913A2/en unknown
- 2019-12-31 WO PCT/TR2019/051264 patent/WO2020176052A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050188991A1 (en) * | 2003-06-04 | 2005-09-01 | Jianuo Sun | Positive airway pressure therapy management module |
US9730632B1 (en) * | 2005-11-04 | 2017-08-15 | Cleveland Medical Devices Inc | Integrated sleep diagnostic and therapeutic system and method |
US20130046151A1 (en) * | 2011-02-14 | 2013-02-21 | The Board Of Regents Of The University Of Texas System | System and method for real-time measurement of sleep quality |
CN103690168A (en) * | 2013-12-31 | 2014-04-02 | 中国科学院深圳先进技术研究院 | Method and system for detecting obstructive sleep apnea syndrome |
Also Published As
Publication number | Publication date |
---|---|
TR201902913A2 (en) | 2019-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8925545B2 (en) | Methods and devices for treating sleep apnea | |
CN101610808B (en) | Pressure support system and method with automatic comfort feature modification | |
CN102405075B (en) | System and method for adjusting tidal volume of a self-ventilating subject | |
CN101601884B (en) | System and method for smart delivery of backup breaths | |
CN107405107B (en) | Respirator and control method thereof | |
CN102711888A (en) | Methods and apparatus for adaptable pressure treatment of sleep disordered breathing | |
TW201538188A (en) | Methods and devices for diagnosis and treatment of respiratory disorders | |
CN103736183A (en) | Pressure control device and method for double-level respirator | |
US20140144445A1 (en) | Substantially Constant Positive Airway Pressure Systems and Methods for Treating Sleep Apnea, Snoring, and Other Respiratory Disorders | |
US12161805B2 (en) | System and method for providing enhanced pap metrics | |
MX2013002835A (en) | Ventilation system. | |
CN110114105A (en) | Determine the pressure support device and method of the variation in patient circuit | |
WO2020176052A1 (en) | A respiratory support device with artificial intelligence | |
US11478595B2 (en) | Method of driving a form of respiratory therapy | |
JP7593459B2 (en) | Systems and methods for increasing compliance with pressure support therapy - Patents.com | |
US12350427B2 (en) | Ventilator control method and ventilator | |
US20250108182A1 (en) | Ventilator control method and ventilator | |
Mayer et al. | Non‐invasive Ventilation | |
Sharun | Must-know Facts about Ventilators for Nurses Working in Intensive Care Units | |
Das et al. | chest wall and the inspiratory time (Ti). Ti should be of sufficient length to | |
Das et al. | Basics of Non-Invasive Ventilation | |
AU2022213834A1 (en) | Systems and methods for retrieving information associated with contents of a container using augmented reality |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19917183 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 19917183 Country of ref document: EP Kind code of ref document: A1 |